Article

Metabolomics data improve 10-year cardiovascular risk prediction with the SCORE2 algorithm for the general population without cardiovascular disease or diabetes

2024-05-04

Abstract excerpt

<h4>ABSTRACT</h4> <h4>BACKGROUND</h4> The value of metabolomic biomarkers for cardiovascular risk prediction is unclear. This study aimed to evaluate the potential of improved prediction of the 10-year risk of major adverse cardiovascular events (MACE) in large population-based cohorts by adding metabolomic biomarkers to the novel SCORE2 model, which was introduced in 2021 for the European population without previ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a497752a-c14e-5554-890e-79a94e226cd7
DOI: 10.1101/2024.04.29.24306593

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metabolomics data improve 10-year cardiovascular risk prediction with the SCORE2 algorithm for the general population without cardiovascular disease or diabetesDOI 10.1101/2024.04.29.24306593Read

Sex-specific proteomic signatures improve cardiovascular risk prediction for the general population without cardiovascular disease or diabetesSemantic proximity Read

Improving cardiovascular risk prediction beyond pooled cohort equations: a prospective cohort of 304,356 participantsSemantic proximity Read

AI-based multiomics profiling for personalized prediction of cardiovascular disease: A prospective UK Biobank studySemantic proximity Read

Advancing cardiovascular disease risk prediction beyond conventional methods: a systematic review of multimodal machine learning models integrating traditional clinical factors and multi-omics dataSemantic proximity Read

Appraising Cardiovascular 10-yr Risk Prediction Scores: A Rapid Systematic ReviewSemantic proximity Read

Large-scale multi-omics enhance risk prediction for type 2 diabetes.Semantic proximity Read

Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index and its derivatives in the prediction of 10-year cardiovascular mortality: insights from MASHAD cohort studySemantic proximity Read

Metabolomic and genomic prediction of common diseases in 477,706 participants in three national biobanksSemantic proximity Read

Risk models and scores for metabolic syndrome: a systematic reviewSemantic proximity Read

Comparative Validation of ASCVD, Framingham Risk Score, Globorisk, and PREVENT for 10-Year Cardiovascular Risk Prediction in the UK BiobankSemantic proximity Read

Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes.Semantic proximity Read

Integrative machine learning approaches for predicting disease risk using multi-omics data from the UK BiobankSemantic proximity Read